Rozumnyi, V. et al. 2026. Sustained disease control with aflibercept 8 mg: A turning point in the management of exudative retinal disease: Expert consenus. Ukrainian Journal of Ophthalmology . 2 (Apr. 2026), 71–76. DOI:https://doi.org/10.31288/Ukr.j.ophthalmol.202627176.